Our Company
Our Company
Our Strategy
Governance
Governance
Board of Directors
Executive Committee
Specialist Committees
Social Impact
Social Impact
Access to Healthcare
Innovation for Vulnerable Communities
Environmental Sustainability and Resilience
Diversity, Equity, and Inclusion In and Beyond the Workplace
Responsible Business Values
Our Legacy
Our Science
Our Science
Our Pipeline
R&D Focus Areas
R&D Focus Areas
Immunology R&D
Neurology R&D
Oncology R&D
Rare Blood Disorders R&D
Rare Diseases R&D
Vaccines R&D
Artificial Intelligence in R&D
Technology Platforms
Clinical trials & results
Clinical trials & results
Clinical Study Results
Investigator Sponsored Studies
Diversity in Clinical Trials
Scientific Collaboration
Scientific Collaboration
Scientific Collaboration in North America
Scientific Collaboration in Europe
Scientific Collaboration in China
Digital
Your Health
Your Health
Vaccines
Vaccines
Influenza
Meningococcal meningitis
Pertussis
Respiratory Syncytial Virus
Production
Why vaccines matter
Medicines
Medicines
Immunology
Neurology
Oncology
Rare Blood Disorders
Rare Diseases
Cardiovascular Diseases
Diabetes
Consumer Healthcare
Consumer Healthcare
Sustainability at Sanofi Consumer Healthcare
Allergy
Cough, Cold & Flu
Digestive Wellness
Pain Care
Physical & Mental Wellness
Patient Support
Healthcare Professionals Support
Healthcare Professionals Support
Managed Access Programs (MAPs)
Pre-Registration Import Licenses
Post Trial Access (PTA)
Partnering
Partnering
Partnering Focus Areas
Partnering Focus Areas
China
Digital
General Medicines
Immunology
Neuroscience
Oncology
Out-Licensing
Rare Disease
Technology Platforms
Vaccines
Meet the Partnering Team
Media
Media
Press Releases
Media Contacts
Sanofi Today
Investor Relations
Investor Relations
Financial Results and Investor Events
Financial Results and Investor Events
Quarterly Results
Investor Presentations
Annual General Meetings
Broker conferences
Environment, Social, Governance
Environment, Social, Governance
Our Double Materiality Assessment
Our Latest ESG news
ESG Newsletters
Individual Shareholders
Individual Shareholders
Being a Shareholder
How to buy Sanofi Shares
Shares and ADRs
Shares and ADRs
Sanofi stock chart
Dividends
ADRs
Shareholding structure
Vara consensus
Shares & voting rights
Share repurchases
Financial Reports and Publications
Financial Reports and Publications
Financial Reports and Regulated Information
Shareholder publications
Financial Reporting Center and Key Data
Contacts
Careers
Careers
Global Terms and Conditions
Paris 2024 Partnership
Paris 2024 Partnership
Team Sanofi
Volunteers
Sanofi Cup
Impulsions 2024
Global
Home
2021-02-12-06-00-00-2174663
Offer Memorandum for All Outstanding Shares of Kiadis Pharma N.V.
February 12, 2021
Download PDF
Share
Offer Memorandum for All Outstanding Shares of Kiadis Pharma N.V.
Attachment
Offer Memorandum
Share
